Explore 3 Stock Ideas & Industry Insights Download Free Report

Stocks

Telix Completes Proof-of-Concept Study of TLX592 Targeted Alpha Therapy in Prostate Cancer

CUPID is a Phase I safety and dosimetry study of TLX592, Telix's investigational antibody-based targeted alpha therapy for prostate cancer. Establishes proof-of-concept for Telix's proprietary RADmAb® engineered antibody platform, currently under pre-clinical evaluation for multiple cancer targets. Initial results demonstrate rapid elimination from blood …

EODHD | 20 May 2024

James Hardie Industries Announces Fourth Quarter And Fiscal Year 2024 Results

Record Net Sales of US$3.9 Billion for the Fiscal Year Record Adjusted Net Income of US$707.5 Million for the Fiscal Year Fourth Quarter Adjusted Net Income of US$174.2 Million Issues First Quarter and Fiscal Year 2025 Guidance SYDNEY & CHICAGO, May 20, 2024--(BUSINESS WIRE)--James …

EODHD | 20 May 2024

Three ASX Dividend Stocks Offering Yields From 3.2% To 8.6%

The Australian stock market has shown a mix of performances recently, with the ASX200 closing up by 0.63%, driven by strong gains in the energy and materials sectors. However, sectors such as healthcare have not fared as well, indicating a varied economic landscape across …

EODHD | 20 May 2024

Emerald Resources Plus Two ASX Growth Stocks With High Insider Stakes

In recent trading sessions, the Australian market has shown a mix of outcomes, with the ASX200 experiencing an uptick of 0.63%, driven primarily by strong performances in the energy and materials sectors. Amidst these market movements, stocks with high insider ownership like Emerald Resources …

EODHD | 20 May 2024

7 Stocks to Buy to Profit from the Russian Uranium Ban

With the world fighting to go green, uranium stocks to buy could blast higher. Not only is uranium seeing significant supply-demand issues, but a recent Congressional ban of Russian uranium imports is also fueling upside. In fact, Congress just passed the Russian uranium import …

EODHD | 20 May 2024

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Achieving those goals is made easier with the Zacks Style Scores, a unique set of guidelines that rates stocks based …

EODHD | 20 May 2024

Nature Communications Publishes Pivotal Data Demonstrating Efficacy and Tolerability of CSL and Arcturus Therapeutics’ COVID-19 Vaccine

Data follow the approval of the world’s first self-amplifying (sa-mRNA) COVID-19 vaccine for adults in Japan. These results add to recently published data on ARCT-154 demonstrating superior immunogenicity to Omicron BA 4/5 compared to conventional mRNA COVID-19 vaccine booster and follow-up data demonstrating longer …

EODHD | 20 May 2024

Exploring ASX Dividend Stocks In May 2024

Despite a challenging day on the ASX200, where most sectors experienced declines, certain stocks demonstrated resilience or noteworthy performance. As investors navigate this landscape, understanding the characteristics that contribute to a stock's stability and potential for reliable dividends becomes particularly valuable in such fluctuating …

EODHD | 19 May 2024

Altus Group Terminates Proposed Acquisition of Situs Group’s Commercial Real Estate Valuation Services Business

Altus Group Limited Transaction unlikely to receive regulatory approval in a timely manner; Altus Group maintains focus on organic strategy to enhance consistency and transparency of valuations within the CRE industry TORONTO, May 17, 2024 (GLOBE NEWSWIRE) -- Altus Group Limited (“Altus Group” or …

EODHD | 17 May 2024

Canfor Announces Voting Results for the Election of Directors

VANCOUVER, BC, May 17, 2024 /CNW/ - Canfor Corporation (TSX: CFP) announces, in accordance with Toronto Stock Exchange requirements, the voting results from its Annual General Meeting held Wednesday, May 01, 2024 in Vancouver, British Columbia. Canfor Corporation logo (CNW Group/Canfor Corp) A total …

EODHD | 17 May 2024
Support

Hi! How can we help you today?

Loading…